Dr. ZHOU, Peng has nearly 20 years of experience in comprehensive ophthalmology in top hospitals and specializes in the diagnosis and treatment of eye diseases, optometry examination, and external eye surgery. He has extensive experience in the treatment of myopia (nearsightedness) control, hyperopia (farsightedness), lazy eye, glaucoma, cataract, uveitis, retinal tear, diabetic retinal disorders, macular degeneration，eyelid bump, and conjunctivitis (pink eyes).
Dr. Zhou completed his research fellowship training in retinal and vitreous diseasesat Doheny Eye Institute (ranked numberseven in the U.S.), University of Southern California after residency training at the Peking University People’s Hospital in Beijing, China. He received his medical doctor degree at Peking University (ranked number one in China).
He is consultant / professor of Ophthalmology at Parkway Health Clinics. He was an associate professor of Ophthalmology at the Eye and ENT Hospital of Fudan University, Shanghai, and the attending ophthalmologist in the Department of Ophthalmology at Peking University People’s Hospital in Beijing.
Dr. Zhou has contributed to over 15 years of clinical and surgical treatment of eye disorders. He first reported the safe effective lowest dose of verteporfin photodynamic therapy for acute central serous chorioretinopathy. He participated in developing the manual small incision 20-gauge pars plana vitrectomy. He also reported the long-term follow-up of local relaxing vitrectomy for stage 4 retinopathy of prematurity.
Furthermore, Dr Zhou is a clinician-scientist in ophthalmology. His academic interest is in age-related diseases of the eye, with an emphasis on the pathogenesis of cataract and age-related macular degeneration (AMD). His papers were published in many academic journals, including Nature Communications. He is the principal investigator (PI) of a National Natural Science Foundation of China that investigated why elderly populations develop age-related cataracts. He was also the secretary of a National Basic Research Program of China (973 Program) that investigated the pathogenesis of AMD.
Dr. Zhou is a committee member of the Chinese Ophthalmology Society, international member of the American Academy of Ophthalmology (AAO),and the Association for Research in Vision and Ophthalmology (ARVO). He is a reviewer for 10 international academic journals, including Ophthalmology, American Journal of Ophthalmology (AJO),and British Journal of Ophthalmology (BJO). By 2017, he had published 18 articles in peer-reviewed journals. Stephen J. Ryan, the chief editor of fifth edition of Retina, invited Dr. Zhou to write two chapters for this book. Also in 2017, he received the Distinguished Service Award, the highest award of the Asia-Pacific Academy of Ophthalmology (the second largest association of ophthalmologists in the world).
Dr. Zhou works at Parkway Health Gleneagles Medical and Surgical Center, located at Tomorrow Square, 4th Floor, 389 Nanjing Xi Road, Shanghai. Please call 400-819-6622 to make an appointment.